ELK1 and left ventricular hypertrophy: As shown in Fig 5, the ability of mutated HRAS to activate both ERK and ELK1 was intermediate between that of wild type and oncogenic HRAS, suggesting that this constitutional activation drives the cell proliferation in left ventricular hypertrophy.